Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000083

Options or other derivatives

  • Director returned 207,500 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Myers Scott Dunseth · Director

Table II: Derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-13 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −20,000 0 D
2023-11-13 Returned to the company : show line 2 in the form Stock Option (Right to Buy) −20,000 0 D
2023-11-13 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −40,000 0 D
2023-11-13 Returned to the company : show line 4 in the form Stock Option (Right to Buy) −40,000 0 D
2023-11-13 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −87,500 $0.93 $81,375 0 D
Loading xslF345X05/wk-form4_1700086561.xml…